학술논문

Predictors of nonadherence to breast cancer screening guidelines in a United States urban comprehensive cancer center.
Document Type
Article
Source
Cancer Medicine. Jul2023, Vol. 12 Issue 14, p15482-15491. 10p.
Subject
*EARLY detection of cancer
*BREAST cancer
*AMERICAN women
*MEDICAL screening
Language
ISSN
2045-7634
Abstract
Background: This study aimed to identify predictors of nonadherence to breast cancer screening guidelines in an urban screening clinic among high‐ and average‐risk women in the United States. Methods: We reviewed records of 6090 women who received ≥2 screening mammograms over 2 years at the Karmanos Cancer Institute to examine how breast cancer risk and breast density were associated with guideline‐concordant screening. Incongruent screening was defined as receiving supplemental imaging between screening mammograms for average‐risk women, and as not receiving recommended supplemental imaging for high‐risk women. We used t‐tests and chi‐square tests to examine bivariate associations with guideline‐congruent screening, and probit regression to regress guideline‐congruence unto breast cancer risk, breast density, and their interaction, controlling for age and race. Results: Incongruent screening was more likely among high‐ versus average‐risk women (97.7% vs. 0.9%, p < 0.01). Among average‐risk women, incongruent screening was more likely among those with dense versus nondense breasts (2.0% vs. 0.1%, p < 0.01). Among high‐risk women, incongruent screening was more likely among those with nondense versus dense breasts (99.5% vs. 95.2%, p < 0.01). The significant main effects of density and high‐risk on increased incongruent screening were qualified by a density by high‐risk interaction, showing a weaker association between risk and incongruent screening among women with dense breasts (simple slope = 3.71, p < 0.01) versus nondense breasts (simple slope = 5.79, p < 0.01). Age and race were not associated with incongruent screening. Conclusions: Lack of adherence to evidence‐based screening guidelines has led to underutilization of supplementary imaging for high‐risk women and potential overutilization for women with dense breasts without other risk factors. [ABSTRACT FROM AUTHOR]